Polypharmakos

Polypharmakos Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $742K
Latest Deal Amount
  • Investors
  • 3

Polypharmakos General Information

Description

Developer of antimicrobial drugs designed to address the emerging global antimicrobial resistance crisis. The company's antimicrobial drugs are prepared from plants, fungi and other natural products for active substances that could form the basis for the development of new drugs and modulators of innate immunity, enabling the customers to have chemical-free drug treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Saint John's Innovation Centre
  • Cowley Road, Milton
  • Cambridge CB4 0WS
  • England, United Kingdom
+44 07831 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Polypharmakos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 30-Jan-2017 $742K 00000 00.000 Completed Startup

Polypharmakos Cap Table

To view Polypharmakos‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 00.000

Polypharmakos Executive Team (2)

Name Title Board Seat Contact Info
John Normanton Co-Founder & Chief Executive Officer
Tom Sopwith Co-Founder & Chief Operating Officer

Polypharmakos Board Members (1)

Name Representing Role Since
Monique Simmonds Polypharmakos Board Member 000 0000

Polypharmakos Investors (3)

To view Polypharmakos‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
Swansea Innovations Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial